Government commits $25m to medicine safety research
The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.
Cost of asthma treatment – a deterrent to use
Cost is a major factor associated with non-adherence to asthma treatment in Australia, recent research revealed. Healthcare providers can assist patients with adherence by...
NSW pharmacists given special authority to supply essential medicines
NSW has granted pharmacists a landmark special authority to supply most S4 medicines without a prescription to those affected by bushfires.
The NSW Chief Health...
From the President: PSA at the FIP World Congress in Seville,...
I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...
Pharmacists in 2023 – unlocking the future of pharmacy
A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...
The importance of a multimodal approach to pain management
The shift from viewing pain as simply a symptom opens up opportunities to greatly improve the way it is treated, writes PainWISE MD Joyce...